Provided by Tiger Trade Technology Pte. Ltd.

ODDITY Tech Ltd.

16.48
+3.4626.53%
Post-market: 16.550.0742+0.45%19:59 EDT
Volume:11.92M
Turnover:194.91M
Market Cap:760.13M
PE:20.86
High:18.44
Open:17.50
Low:14.57
Close:13.03
52wk High:64.23
52wk Low:9.25
Shares:46.12M
Float Shares:28.59M
Volume Ratio:14.94
T/O Rate:41.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7900
EPS(LYR):1.80
ROE:16.40%
ROA:3.99%
PB:2.54
PE(LYR):9.16

Loading ...

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise

GlobeNewswire
·
Aug 03

Press Release: Radiopharm Theranostics Reports Business Update

Dow Jones
·
Jul 31

ODDITY Tech Shareholders Approve All Proposals at 2026 Annual Meeting

TIPRANKS
·
Jul 31

5 Microcap Software Stocks Expected to Soar by Triple Digits as the Companies' Sales Pop

Dow Jones
·
Jul 30

ODDITY to Announce Second Quarter 2026 Financial Results on September 9, 2026

GlobeNewswire
·
Jul 23

Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

GlobeNewswire
·
Jul 21

Oddity Tech CFO Lindsay Drucker Mann Disposes of USD 1.65 Million in Common Shares

Reuters
·
Jul 01

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

GlobeNewswire
·
Jun 30

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants

GlobeNewswire
·
Jun 22

Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026

GlobeNewswire
·
Jun 22

Oddity Tech board expands share buyback distribution up to $200 million under Israeli Companies Law

Reuters
·
Jun 17

ODDITY Tech Sets July 29, 2026 AGM to Vote on Board, Auditor and Governance Matters

TIPRANKS
·
Jun 17

Oddity Tech announces annual shareholder meeting

Reuters
·
Jun 17

Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026

GlobeNewswire
·
Jun 15

Oddity Tech Unit to Repurchase $50 Million of Exchangeable Senior Notes

MT Newswires Live
·
Jun 12

ODDITY Tech to Repurchase $50 Million of Exchangeable Notes at Discount

TIPRANKS
·
Jun 12

Oddity Tech: Unit Entered Into Separate, Privately Negotiated Repurchase Deals

THOMSON REUTERS
·
Jun 12

Oddity Tech: Deals With Holders of $50 Mln in Aggregate Principal Amount of 0% Exchangeable Senior Notes Due 2030 of Oddity Finance

THOMSON REUTERS
·
Jun 12

Oddity Tech Ltd: Repurchases Expected to Close on June 17, 2026 for Purchase Price of $35 Mln- SEC Filing

THOMSON REUTERS
·
Jun 12

Oddity Tech unit repurchases $50 million of 0% exchangeable senior notes due 2030 for $35 million

Reuters
·
Jun 12